According to the results of the assessment of the investment portfolio of RVC as of the end of the third quarter of 2020, the return on capital indicator (TVPI) exceeded the figure of one.
-
Investment Activity
-
NTI and Technological Development
-
NTI Project Office
Russian Venture Company (RVC JSC) is a state fund of funds and a development institution in the Russian venture capital market.
The mission of the company is to create a mature venture capital market through the consolidation and development of resources, competencies and initiatives on the part of investors, investment portfolio managers and entrepreneurs so as to create and promote innovative products and technologies in priority technology areas, making Russia a leader in the global technology market.
More
Media Center
03.12.2020
The first stage of testing the microwave radiothermometry (RTM) technology for diagnosing pulmonary complications in COVID-19 patients has been summed up. Their results showed that using this technology is a convenient and safe method of screening diagnostics in patients with COVID-19 with suspected pneumonia.
02.12.2020
The CTRP Group and GenerationS have summed up the corporate acceleration program results to find innovative projects for the pipe industry.
30.11.2020
GenerationS, a corporate innovation development platform from RVC, has completed its projects scouting for Lenta — the largest hypermarket chain in Russia. The first selection focus was international projects capable of offering competitive, mature solutions for the retail industry in critical areas.
02.12.2020
The CTRP Group and GenerationS have summed up the corporate acceleration program results to find innovative projects for the pipe industry.
30.11.2020
GenerationS, a corporate innovation development platform from RVC, has completed its projects scouting for Lenta — the largest hypermarket chain in Russia. The first selection focus was international projects capable of offering competitive, mature solutions for the retail industry in critical areas.
25.11.2020
The acceptance of applications for the Olympiad of the NTI Club Movement has ended. Eighty thousand nine hundred twenty schoolchildren from 85 regions of Russia took part in the Olympiad.
03.12.2020
The first stage of testing the microwave radiothermometry (RTM) technology for diagnosing pulmonary complications in COVID-19 patients has been summed up. Their results showed that using this technology is a convenient and safe method of screening diagnostics in patients with COVID-19 with suspected pneumonia.
26.11.2020
The RVC Biofund closed the deal to sell its 17.79% stake in the Genetico portfolio company Center for Genetics and Reproductive Medicine (hereinafter — Genetico).
24.11.2020
According to the results of the assessment of the investment portfolio of RVC as of the end of the third quarter of 2020, the return on capital indicator (TVPI) exceeded the figure of one.